Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Almeida

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
International Journal of Environmental Research and Public Health|June 10, 2023
Managing Nanomaterials in the Workplace by Using the Control Banding ApproachDelfina Ramos, Luis Almeida
Sensors (Basel, Switzerland)|February 26, 2022
Optimal Relay Network for Aerial Remote InspectionsLuis Ramos Pinto, Luis Almeida
Sensors (Basel, Switzerland)|December 22, 2018
A Robust Approach to TDMA Synchronization in Aerial NetworksLuis Ramos Pinto, Luis Almeida
Drugs in R&D|September 4, 2003
Safety, tolerability and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic agent, during first administration to humansLuis Almeida, Patrício Soares-da-Silva
Current Biology : CB|June 20, 2003
Drosophila morphogenesis: the Newtonian revolutionRaphaël Rousset, Luis Almeida, Stéphane Noselli
Sensors (Basel, Switzerland)|May 20, 2022
Extending MQTT with Real-Time Communication Services Based on SDNEhsan Shahri, Paulo Pedreiras, Luis Almeida
Biotechnology and Applied Biochemistry|June 14, 2020
Microfluidic-assisted fabrication of reverse micelle/PLGA hybrid microspheres for sustained vascular endothelial growth factor deliveryMeisam Omidi, Luis Almeida, Lobat Tayebi
Journal of Clinical Pharmacology|August 3, 2004
Safety, tolerability, and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humansLuis Almeida, Patrício Soares-da-Silva
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
Eslicarbazepine acetate (BIA 2-093)Luis Almeida, Patrício Soares-da-Silva
Drugs in R&D|July 10, 2003
Pharmacokinetics and pharmacodynamics of BIA 3-202, a novel COMT inhibitor, during first administration to humansLuis Almeida, Patrício Soares-da-Silva
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
International Journal of Environmental Research and Public Health|June 10, 2023
Managing Nanomaterials in the Workplace by Using the Control Banding ApproachDelfina Ramos, Luis Almeida
Sensors (Basel, Switzerland)|February 26, 2022
Optimal Relay Network for Aerial Remote InspectionsLuis Ramos Pinto, Luis Almeida
Sensors (Basel, Switzerland)|December 22, 2018
A Robust Approach to TDMA Synchronization in Aerial NetworksLuis Ramos Pinto, Luis Almeida
Drugs in R&D|September 4, 2003
Safety, tolerability and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic agent, during first administration to humansLuis Almeida, Patrício Soares-da-Silva
Current Biology : CB|June 20, 2003
Drosophila morphogenesis: the Newtonian revolutionRaphaël Rousset, Luis Almeida, Stéphane Noselli
Sensors (Basel, Switzerland)|May 20, 2022
Extending MQTT with Real-Time Communication Services Based on SDNEhsan Shahri, Paulo Pedreiras, Luis Almeida
Biotechnology and Applied Biochemistry|June 14, 2020
Microfluidic-assisted fabrication of reverse micelle/PLGA hybrid microspheres for sustained vascular endothelial growth factor deliveryMeisam Omidi, Luis Almeida, Lobat Tayebi
Journal of Clinical Pharmacology|August 3, 2004
Safety, tolerability, and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humansLuis Almeida, Patrício Soares-da-Silva
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
Eslicarbazepine acetate (BIA 2-093)Luis Almeida, Patrício Soares-da-Silva
Drugs in R&D|July 10, 2003
Pharmacokinetics and pharmacodynamics of BIA 3-202, a novel COMT inhibitor, during first administration to humansLuis Almeida, Patrício Soares-da-Silva
Pageof 14